Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tulsi Amrit
- Development stage
- Unknown
- Lead developer
- Tulsi Amrit
- Administration
- Oral
01
Overview
Tulsi Amrit is a consumer herbal supplement and traditional Ayurvedic formulation developed and manufactured by Paawan Herbal. It is marketed as a concentrated extract derived from multiple varieties of the Tulsi plant (Holy Basil, *Ocimum sanctum*). As a patented consumer product rather than a pharmaceutical drug candidate, it does not have defined molecular targets or clinical development phases in the conventional biotech sense. It is typically used for immune support and respiratory health and is administered orally, often in the form of liquid drops.
- Brand names
- Tulsi Amrit
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ER (Estrogen receptor)GABRR (GABA-A receptor subunit rho)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Tulsi Amrit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tulsi Amrit.